WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

C CARDIOVASCULAR SYSTEM

This group comprises substances used for the treatment of cardiovascular conditions.
Drugs used for the treatment of hypertension are classified in C02 - Antihypertensives, C03 - Diuretics, C07 - Beta blocking agents, C08 - Calcium channel blockers, and C09 - Agents acting on the renin-angiotensin system. For the classification of combination products of antihypertensives from different ATC groups, the following ranking should be used, from higher to lower precedence: C09, C07, C08, and C03.


C05 VASOPROTECTIVES


No DDDs are established in this group, since most of the drugs in this group are for topical use.


C05C CAPILLARY STABILIZING AGENTS
C05CA Bioflavonoids

Rutoside is classified in this group.
Oxerutines are classified in C05CA54.
Combinations with other capillary stabilizing agents are classified at separate 5th levels using the corresponding 50-series.


    ATC code  Name  DDD  U Adm.R Note
    C05CA05 hidrosmin    

List of abbreviations

Last updated: 2024-01-26